{"filings":[{"id":1500477,"accession_number":"0001104659-26-081305","cik":1725255,"company_name":"AdaptHealth Corp.","ticker":"AHCO","form_type":"8-K","filed_at":"2026-07-07T20:45:49+00:00","items":["7.01"],"status":"ready","headline":"AdaptHealth subsidiary calls $325M 6.125% Senior Notes due 2028 for redemption","summary_kind":"llm","event_type":"debt","confidence":"high","bullets":["Issuer (AdaptHealth LLC) redeemed all $325M 6.125% Senior Notes due 2028.","Redemption price: 100% of principal plus accrued interest to Aug 1, 2026.","Conditioned on receipt of net proceeds from a delayed draw term loan facility.","Redemption date expected Aug 1, 2026; payment on Aug 3, 2026."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.5,"calibrated_materiality_score":0.5,"market_cap_usd":1378228528.7442086,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":1414796,"accession_number":"0001104659-26-080297","cik":1725255,"company_name":"AdaptHealth Corp.","ticker":"AHCO","form_type":"8-K","filed_at":"2026-07-02T20:01:45+00:00","items":["1.05"],"status":"ready","headline":"AdaptHealth reports material cybersecurity incident; patient data exfiltrated via social engineering","summary_kind":"llm","event_type":"cyber","confidence":"high","bullets":["Threat actor gained unauthorized access to cloud-based business applications including patient management systems and document storage.","Exfiltrated data includes passwords for insurance billing and patient personally identifiable and protected health information.","Incident resulted from social engineering attack on a third-party contractor; compromised user session disabled and credentials reset.","Company determined incident material on June 27, 2026; investigation ongoing with external forensics.","No material operational impact to date; full financial impact including remediation and legal costs not yet determinable."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"negative","materiality_score":0.75,"calibrated_materiality_score":0.75,"market_cap_usd":1378228528.7442086,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":1195196,"accession_number":"0001104659-26-076390","cik":1725255,"company_name":"AdaptHealth Corp.","ticker":"AHCO","form_type":"8-K","filed_at":"2026-06-22T20:16:23+00:00","items":["5.07"],"status":"ready","headline":"AdaptHealth stockholders elect all nine director nominees, ratify KPMG, and approve say-on-pay at 2026 annual meeting","summary_kind":"llm","event_type":"other","confidence":"high","bullets":["All nine director nominees elected with over 100M votes each; broker non-votes of ~11.9M shares.","Ratification of KPMG LLP as independent auditor for FY2026: 119,090,024 for, 1,092,126 against, 470,343 abstain.","Non-binding advisory approval of executive compensation: 107,129,368 for, 965,272 against, 682,032 abstain.","Quorum established with 120,652,493 shares (88.67% of voting power) present at meeting."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.0,"calibrated_materiality_score":0.0,"market_cap_usd":1378228528.7442086,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":787007,"accession_number":"0001104659-26-069119","cik":1725255,"company_name":"AdaptHealth Corp.","ticker":"AHCO","form_type":"8-K/A","filed_at":"2026-06-02T01:02:57+00:00","items":["5.02","9.01"],"status":"ready","headline":"AdaptHealth amends 8-K to disclose COO Daniel McFadden's compensation: base salary raised to $550K, plus RSU grant","summary_kind":"llm","event_type":"leadership","confidence":"high","bullets":["Base salary increased from $410K to $550K retroactive to May 4, 2026.","Annual target bonus set at 100% of base salary, pro-rated for FY2026.","One-time RSU grant valued at $464,110 with time-based (50%, 3-yr) and TSR-based (50%, 0-200%) vesting.","Grant is under the Second Amended and Restated 2019 Stock Incentive Plan.","This amends prior filing to correct date and add compensation details not previously determined."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.4,"calibrated_materiality_score":0.4,"market_cap_usd":1378228528.7442086,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":95018,"accession_number":"0001628280-26-030120","cik":1725255,"company_name":"AdaptHealth Corp.","ticker":"AHCO","form_type":"8-K","filed_at":"2026-05-05T23:59:59+00:00","items":["2.02","5.02","9.01"],"status":"ready","headline":"AdaptHealth Q1 net loss widens to $16M, COO replaced; raises revenue guidance","summary_kind":"llm","event_type":"earnings","confidence":"high","bullets":["Net revenue $819.8M (+5.4% YoY); net loss $16.0M vs $7.2M loss in Q1 2025.","Adjusted EBITDA $121.2M, down 5.3% YoY; free cash flow negative $27.5M.","FY 2026 net revenue guidance raised $10M to $3.45-3.52B; EBITDA and FCF guidance maintained.","COO Toby Scott Barnhart terminated May 4; replaced by Daniel McFadden (Chief Business Systems Officer).","Completed $1.1B refinancing in April, reducing near-term amortization and lowering average debt cost."],"consensus_eps_estimate":null,"consensus_eps_actual":-0.12,"consensus_revenue_estimate":null,"consensus_revenue_actual":819799000.0,"consensus_period":"2026-Q1","consensus_source":"xbrl_only","sentiment":"negative","materiality_score":0.7,"calibrated_materiality_score":0.7,"market_cap_usd":1378228528.7442086,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":95017,"accession_number":"0001628280-26-024835","cik":1725255,"company_name":"AdaptHealth Corp.","ticker":"AHCO","form_type":"8-K","filed_at":"2026-04-13T23:59:59+00:00","items":["1.01","1.02","2.03","7.01","9.01"],"status":"ready","headline":"AdaptHealth closes $1.1B credit facility with reduced pricing and extended maturity to 2031","summary_kind":"llm","event_type":"debt","confidence":"high","bullets":["New facility: $325M term loan, $325M delayed draw term loan, $450M revolver (previously $300M).","Proceeds repaid existing term loan and $100M drawn revolver; no penalty.","Delayed draw facility to redeem $325M 6.125% Senior Notes due 2028 when callable at par in Aug 2026.","Pricing grid reduced to 1.125%–2.000% over SOFR; weighted avg cost of debt to decrease by at least 25 bps after note redemption.","Maturity extended ~2 years to April 2031; no impact on previously issued FY2026 guidance."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"positive","materiality_score":0.65,"calibrated_materiality_score":0.65,"market_cap_usd":1378228528.7442086,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":107787,"accession_number":"0001628280-26-010872","cik":1725255,"company_name":"AdaptHealth Corp.","ticker":"AHCO","form_type":"8-K","filed_at":"2026-02-24T23:59:59+00:00","items":["2.02","9.01"],"status":"ready","headline":"AdaptHealth reports Q4 net loss $102.8M, FY net loss $70.8M; guides FY2026 rev up to $3.51B, EBITDA $680-730M","summary_kind":"llm","event_type":"earnings","confidence":"high","bullets":["Full-year 2025 net loss $70.8M vs net income $90.4M in 2024; includes $128M goodwill impairment.","Q4 2025 net revenue $846.3M (-1.2% YoY); Adjusted EBITDA $163.1M (-18.7%).","FY 2025 Adjusted EBITDA $616.7M (-10.5%); free cash flow $219.4M.","2026 guidance: Net revenue $3.44B-$3.51B, Adjusted EBITDA $680M-$730M, free cash flow $175M-$225M.","Debt reduced $250M in FY 2025; credit upgrades from S&P and Moody's; patient census records set."],"consensus_eps_estimate":null,"consensus_eps_actual":-0.52,"consensus_revenue_estimate":null,"consensus_revenue_actual":3244857000.0,"consensus_period":"2025-FY","consensus_source":"xbrl_only","sentiment":"neutral","materiality_score":0.75,"calibrated_materiality_score":0.75,"market_cap_usd":1378228528.7442086,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":124180,"accession_number":"0001628280-25-048527","cik":1725255,"company_name":"AdaptHealth Corp.","ticker":"AHCO","form_type":"8-K","filed_at":"2025-11-04T23:59:59+00:00","items":["2.02","9.01"],"status":"ready","headline":"AdaptHealth Q3 net revenue $820.3M (+1.8%), adj. EBITDA $170.1M (+3.5%) beat expectations; organic growth 5.1%","summary_kind":"llm","event_type":"earnings","confidence":"high","bullets":["Net income $24.5M vs $22.9M; YTD free cash flow $140.1M vs $162.7M.","Reduced debt by $225M YTD; net leverage ratio 2.68x (target 2.50x).","Signed capitated HME deal for ~170k members; myApp users up 271k from 118k.","Maintained FY2025 guidance: rev $3.18-3.26B, adj. EBITDA $642-682M, FCF $170-190M."],"consensus_eps_estimate":null,"consensus_eps_actual":0.21,"consensus_revenue_estimate":null,"consensus_revenue_actual":2398568000.0,"consensus_period":"2025-Q3","consensus_source":"xbrl_only","sentiment":"positive","materiality_score":0.75,"calibrated_materiality_score":0.75,"market_cap_usd":1378228528.7442086,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":140844,"accession_number":"0001628280-25-037598","cik":1725255,"company_name":"AdaptHealth Corp.","ticker":"AHCO","form_type":"8-K","filed_at":"2025-08-05T23:59:59+00:00","items":["2.02","9.01"],"status":"ready","headline":"AdaptHealth Q2 2025 revenue $800.4M, net income $14.7M; lowers FY adjusted EBITDA guidance","summary_kind":"llm","event_type":"earnings","confidence":"high","bullets":["Net revenue $800.4M, down 0.7% YoY; net income $14.7M vs $19.4M in prior year.","Adjusted EBITDA $155.5M, down 5.9% YoY; year-to-date cash flow from ops $257.5M.","FY 2025 revenue guidance narrowed to $3.18B-$3.26B; adjusted EBITDA lowered to $642M-$682M.","Closed sales of certain incontinence and infusion assets in Wellness at Home segment.","Announces new capitated partnership with a major national healthcare system (no details)."],"consensus_eps_estimate":null,"consensus_eps_actual":0.05,"consensus_revenue_estimate":null,"consensus_revenue_actual":1578254000.0,"consensus_period":"2025-Q2","consensus_source":"xbrl_only","sentiment":"negative","materiality_score":0.7,"calibrated_materiality_score":0.7,"market_cap_usd":1378228528.7442086,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":140843,"accession_number":"0001104659-25-073912","cik":1725255,"company_name":"AdaptHealth Corp.","ticker":"AHCO","form_type":"8-K","filed_at":"2025-08-05T23:59:59+00:00","items":["7.01","9.01"],"status":"ready","headline":"AdaptHealth signs exclusive 5-year capitated HME partnership with major national health system covering 10M+ members","summary_kind":"llm","event_type":"other_material","confidence":"high","bullets":["Partnership with a large California-based integrated delivery network; exclusive provider of HME for its 10M+ members.","5-year capitated agreement covering Medicare Advantage, Medicaid Managed Care, and privately insured patients.","CEO Suzanne Foster says the deal demonstrates AdaptHealth's ability to drive non-acquired growth through innovative arrangements.","Agreement shifts to capitation payment model, providing predictable revenue stream across a large patient base."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"positive","materiality_score":0.75,"calibrated_materiality_score":0.75,"market_cap_usd":1378228528.7442086,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":158593,"accession_number":"0001104659-25-064140","cik":1725255,"company_name":"AdaptHealth Corp.","ticker":"AHCO","form_type":"8-K","filed_at":"2025-06-30T23:59:59+00:00","items":["7.01","9.01"],"status":"ready","headline":"AdaptHealth closes infusion asset sale, reduces debt by $65M, updates FY2025 guidance","summary_kind":"llm","event_type":"m_and_a","confidence":"high","bullets":["Closed disposition of certain infusion assets in Wellness at Home segment; assets had ~$52M annual revenue and ~$5M annual Adjusted EBITDA.","Used proceeds for $65M term loan prepayment; cumulative $135M debt reduction (including $70M prepayment in May).","Revised FY2025 guidance: revenue $3,150M-$3,290M; Adjusted EBITDA $662M-$702M; Free Cash Flow $170M-$190M.","Company expects $30M cash taxes on gains from this disposition."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"positive","materiality_score":0.65,"calibrated_materiality_score":0.65,"market_cap_usd":1378228528.7442086,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":158592,"accession_number":"0001104659-25-061172","cik":1725255,"company_name":"AdaptHealth Corp.","ticker":"AHCO","form_type":"8-K","filed_at":"2025-06-20T23:59:59+00:00","items":["5.07"],"status":"ready","headline":"AdaptHealth stockholders elect six directors, ratify KPMG, approve executive compensation","summary_kind":"llm","event_type":"other","confidence":"high","bullets":["All six director nominees elected: Connors, Coppens, Lundberg, Weaver, Williams III, Wolf.","KPMG LLP ratified as independent auditor for FY2025: 124.3M for, 2.1M against, 112K abstain.","Non-binding advisory vote on executive compensation approved: 105.7M for, 6.4M against, 14.3M broker non-votes."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.1,"calibrated_materiality_score":0.1,"market_cap_usd":1378228528.7442086,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":158591,"accession_number":"0001628280-25-022394","cik":1725255,"company_name":"AdaptHealth Corp.","ticker":"AHCO","form_type":"8-K","filed_at":"2025-05-06T23:59:59+00:00","items":["2.02","9.01"],"status":"ready","headline":"AdaptHealth Q1 revenue down 1.8% to $778M; net loss widens; guides FY25 lower on asset sales","summary_kind":"llm","event_type":"earnings","confidence":"high","bullets":["Net revenue $777.9M (-1.8% YoY); net loss $7.2M vs $2.1M loss prior year.","Adjusted EBITDA $127.9M (-19.3% YoY); operating cash flow improved to $95.5M.","Sold incontinence assets; signed deal to sell infusion assets (closes Q2 2025).","FY2025 guidance reduced: revenue $3.18B-$3.32B, Adj. EBITDA $665M-$705M.","Diabetes segment improved for second consecutive quarter."],"consensus_eps_estimate":null,"consensus_eps_actual":-0.05,"consensus_revenue_estimate":null,"consensus_revenue_actual":777882000.0,"consensus_period":"2025-Q1","consensus_source":"xbrl_only","sentiment":"negative","materiality_score":0.7,"calibrated_materiality_score":0.7,"market_cap_usd":1378228528.7442086,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":176985,"accession_number":"0001628280-25-007553","cik":1725255,"company_name":"AdaptHealth Corp.","ticker":"AHCO","form_type":"8-K","filed_at":"2025-02-25T23:59:59+00:00","items":["2.02","9.01"],"status":"ready","headline":"AdaptHealth reports FY2024 net income of $90.4M vs prior year loss; revenue up 1.9%","summary_kind":"llm","event_type":"earnings","confidence":"high","bullets":["FY2024 net revenue $3.261B (+1.9% YoY); net income attributable $90.4M vs net loss $678.9M.","Adjusted EBITDA $688.7M (+2.7% YoY); cash flow from ops $541.8M, free cash flow $235.8M.","Q4 net revenue $856.6M (-0.2% YoY); net income $50.3M vs loss $254.5M; adjusted EBITDA $200.6M.","FY2025 guidance: net revenue $3.22B-$3.36B; adjusted EBITDA $670M-$710M; free cash flow $180M-$220M.","Reached definitive agreement to sell certain incontinence assets in Wellness at Home segment."],"consensus_eps_estimate":null,"consensus_eps_actual":0.61,"consensus_revenue_estimate":null,"consensus_revenue_actual":3260975000.0,"consensus_period":"2024-FY","consensus_source":"xbrl_only","sentiment":"positive","materiality_score":0.7,"calibrated_materiality_score":0.7,"market_cap_usd":1378228528.7442086,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":193772,"accession_number":"0001104659-24-128292","cik":1725255,"company_name":"AdaptHealth Corp.","ticker":"AHCO","form_type":"8-K","filed_at":"2024-12-13T23:59:59+00:00","items":["5.02","9.01"],"status":"ready","headline":"AdaptHealth cuts CBO Rietkerk's salary to $125k amid transition; separation March 31","summary_kind":"llm","event_type":"leadership","confidence":"high","bullets":["Shaw Rietkerk's annual base salary reduced from $500,000 to $125,000 effective January 1, 2025.","Amendment to August 2024 transition agreement; separation date remains March 31, 2025.","All other terms of prior transition agreement unchanged.","CEO Suzanne Foster countersigned the amendment on December 9, 2024."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.3,"calibrated_materiality_score":0.3,"market_cap_usd":1378228528.7442086,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":193771,"accession_number":"0001628280-24-045113","cik":1725255,"company_name":"AdaptHealth Corp.","ticker":"AHCO","form_type":"8-K","filed_at":"2024-11-05T23:59:59+00:00","items":["2.02","9.01"],"status":"ready","headline":"AdaptHealth Q3 net income $22.9M, revenue $805.9M; raises free cash flow guidance","summary_kind":"llm","event_type":"earnings","confidence":"high","bullets":["Net income attributable to AdaptHealth of $22.9M vs net loss of $454.1M in Q3 2023.","Revenue $805.9M, up 0.2% YoY; Adjusted EBITDA $164.3M, up 1.9%.","FY 2024 guidance updated: revenue $3.22-3.26B (down), adjusted EBITDA $655-675M (narrowed), free cash flow $175-195M (up from $160-180M).","Year-to-date free cash flow $162.7M, more than double prior year's $76.6M.","Completed sale of certain custom rehab assets during the quarter."],"consensus_eps_estimate":null,"consensus_eps_actual":0.27,"consensus_revenue_estimate":null,"consensus_revenue_actual":2404330000.0,"consensus_period":"2024-Q3","consensus_source":"xbrl_only","sentiment":"positive","materiality_score":0.7,"calibrated_materiality_score":0.7,"market_cap_usd":1378228528.7442086,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":193770,"accession_number":"0001104659-24-112672","cik":1725255,"company_name":"AdaptHealth Corp.","ticker":"AHCO","form_type":"8-K","filed_at":"2024-10-30T23:59:59+00:00","items":["5.02","9.01"],"status":"ready","headline":"AdaptHealth enters new CTO employment agreement with Albert Prast; base salary $450K","summary_kind":"llm","event_type":"leadership","confidence":"high","bullets":["Annual base salary of $450,000; target annual bonus of 100% of base salary.","Eligible for equity awards beginning 2025; Compensation Committee intends $1M annual grant.","Severance: 18 months base salary continuation plus COBRA on qualifying termination.","Restrictive covenants include 18-month non-compete, 24-month non-solicit, indefinite confidentiality.","New agreement dated Oct 30, 2024 supersedes prior July 2023 employment contract."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.3,"calibrated_materiality_score":0.3,"market_cap_usd":1378228528.7442086,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":193769,"accession_number":"0001104659-24-110349","cik":1725255,"company_name":"AdaptHealth Corp.","ticker":"AHCO","form_type":"8-K","filed_at":"2024-10-22T23:59:59+00:00","items":["5.02","7.01","9.01"],"status":"ready","headline":"AdaptHealth appoints Diana Nole to Board of Directors effective Oct 16, 2024","summary_kind":"llm","event_type":"leadership","confidence":"high","bullets":["Diana Nole, age 59, appointed as Class I director; term expires at 2026 annual meeting.","Most recently EVP & GM of Healthcare at Nuance Communications (Microsoft); previously CEO of Wolters Kluwer Healthcare.","Board determined she is independent under Nasdaq and SEC rules.","Will receive standard non-employee director compensation, pro-rated for current year.","Company entered into indemnification agreement with Nole, form filed as Exhibit 10.1."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.4,"calibrated_materiality_score":0.4,"market_cap_usd":1378228528.7442086,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":210098,"accession_number":"0001104659-24-104290","cik":1725255,"company_name":"AdaptHealth Corp.","ticker":"AHCO","form_type":"8-K","filed_at":"2024-09-30T23:59:59+00:00","items":["7.01","9.01"],"status":"ready","headline":"AdaptHealth corrects private warrant expiry to Nov 8, 2024 from previously reported Nov 20","summary_kind":"llm","event_type":"other_material","confidence":"high","bullets":["Notice to private placement warrant holders confirms expiration date is November 8, 2024 at 5:00 PM ET.","Company previously incorrectly reported expiration as November 20, 2024 in periodic filings.","Any warrants not exercised by the Expiration Date become void.","Terms of warrants unchanged; exercise still subject to Warrant Agreement conditions."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.6,"calibrated_materiality_score":0.6,"market_cap_usd":1378228528.7442086,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":210097,"accession_number":"0001104659-24-100033","cik":1725255,"company_name":"AdaptHealth Corp.","ticker":"AHCO","form_type":"8-K","filed_at":"2024-09-16T23:59:59+00:00","items":["1.01","2.03","7.01","9.01"],"status":"ready","headline":"AdaptHealth closes $950M senior secured credit facility, extends maturity to 2029, reduces cost of debt","summary_kind":"llm","event_type":"debt","confidence":"high","bullets":["New facility: $650M Term Loan A (fully funded) + $300M Revolver, replacing $450M revolver and existing term loan due Jan 2026.","Maturity extended to September 13, 2029; interest rate pricing decreased from prior credit facility.","Proceeds used to fully repay existing Term Loan with no penalty; undrawn commitment fees reduced.","13 lenders including Regions Bank, BofA, Capital One, Citizens, Fifth Third, JPMorgan, Truist."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"positive","materiality_score":0.65,"calibrated_materiality_score":0.65,"market_cap_usd":1378228528.7442086,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":210096,"accession_number":"0001104659-24-092623","cik":1725255,"company_name":"AdaptHealth Corp.","ticker":"AHCO","form_type":"8-K","filed_at":"2024-08-26T23:59:59+00:00","items":["5.02","7.01","9.01"],"status":"ready","headline":"AdaptHealth appoints Scott Barnhart as COO; Shaw Rietkerk transitions to Chief Business Officer","summary_kind":"llm","event_type":"leadership","confidence":"high","bullets":["Scott Barnhart appointed COO effective Sep 23, 2024; previously COO of Qurate Retail Group and President at Cardinal Health.","Barnhart receives $600K base salary, 100% target bonus, and $1M RSU inducement grant vesting over 3 years.","Shaw Rietkerk moves to Chief Business Officer until Mar 31, 2025; receives $750K transition payment and continued equity vesting.","Rietkerk waives 2024 target bonus and contractual severance in exchange for transition benefits.","Barnhart brings 30+ years ops experience; CEO says change supports organizational alignment and growth."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.55,"calibrated_materiality_score":0.55,"market_cap_usd":1378228528.7442086,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":210095,"accession_number":"0001104659-24-090892","cik":1725255,"company_name":"AdaptHealth Corp.","ticker":"AHCO","form_type":"8-K","filed_at":"2024-08-19T23:59:59+00:00","items":["5.02"],"status":"ready","headline":"AdaptHealth COO Shaw Rietkerk to step down, named Chief Business Officer","summary_kind":"llm","event_type":"leadership","confidence":"high","bullets":["Shaw Rietkerk informed by AdaptHealth on Aug 13, 2024 of planned transition to Chief Business Officer.","Rietkerk will cease serving as COO by end of September 2024; new role effective thereafter.","Company and Rietkerk are currently negotiating terms of the transition."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.4,"calibrated_materiality_score":0.4,"market_cap_usd":1378228528.7442086,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":210094,"accession_number":"0001628280-24-034954","cik":1725255,"company_name":"AdaptHealth Corp.","ticker":"AHCO","form_type":"8-K","filed_at":"2024-08-06T23:59:59+00:00","items":["2.02","9.01"],"status":"ready","headline":"AdaptHealth Q2 revenue $806M (+1.6% YoY); net income $19.4M; narrows guidance","summary_kind":"llm","event_type":"earnings","confidence":"high","bullets":["Net revenue $806.0M vs $793.3M YoY; net income $19.4M (+39%); adjusted EBITDA $165.3M (-3.3%).","Year-to-date operating cash flow $247.0M (+$20.4M YoY); free cash flow $77.9M (+$23.1M).","Signed definitive agreement to divest certain non-core assets; closing expected Q3 2024.","FY2024 guidance: net revenue $3.255-3.315B, adj. EBITDA $660-700M, free cash flow $160-180M.","CEO Suzanne Foster noted results in line with expectations; optimistic about unified team effort."],"consensus_eps_estimate":null,"consensus_eps_actual":0.12,"consensus_revenue_estimate":null,"consensus_revenue_actual":1598472000.0,"consensus_period":"2024-Q2","consensus_source":"xbrl_only","sentiment":"neutral","materiality_score":0.6,"calibrated_materiality_score":0.6,"market_cap_usd":1378228528.7442086,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":210093,"accession_number":"0001104659-24-077607","cik":1725255,"company_name":"AdaptHealth Corp.","ticker":"AHCO","form_type":"8-K","filed_at":"2024-07-03T23:59:59+00:00","items":["5.02","7.01","8.01","9.01"],"status":"ready","headline":"AdaptHealth President Josh Parnes to resign, Dale Wolf named Board Chair","summary_kind":"llm","event_type":"leadership","confidence":"high","bullets":["Josh Parnes steps down as President effective Aug 31, 2024, and from Board Dec 31, 2024.","Dale Wolf appointed Chair of Board effective July 1, 2024, replacing outgoing Chair Richard Barasch.","CEO Suzanne Foster joined Board effective May 20, 2024.","Parnes receives contractual severance, prorated 2024 bonus, and COBRA; equity treated as termination without cause."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.6,"calibrated_materiality_score":0.6,"market_cap_usd":1378228528.7442086,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":228333,"accession_number":"0001104659-24-073974","cik":1725255,"company_name":"AdaptHealth Corp.","ticker":"AHCO","form_type":"8-K","filed_at":"2024-06-21T23:59:59+00:00","items":["5.02","5.03","5.07","9.01"],"status":"ready","headline":"AdaptHealth shareholders approve de-staggered board, officer exculpation, and 8.35M share increase to equity plan","summary_kind":"llm","event_type":"other_material","confidence":"high","bullets":["Shareholders approved board declassification; directors elected after 2024 will serve one-year terms, phase-out complete by 2026.","Stockholders approved officer exculpation amendment to certificate of incorporation under new Delaware law.","8,350,000 new shares added to 2019 Stock Incentive Plan; plan termination date extended to 2034.","Directors Terence Connors, Ted Lundberg, Joshua Parnes, David Williams III elected to one-year terms.","KPMG LLP ratified as independent auditor for FY 2024; advisory say-on-pay passed with 94.4M votes for."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.55,"calibrated_materiality_score":0.55,"market_cap_usd":1378228528.7442086,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":228332,"accession_number":"0001628280-24-020835","cik":1725255,"company_name":"AdaptHealth Corp.","ticker":"AHCO","form_type":"8-K","filed_at":"2024-05-07T23:59:59+00:00","items":["2.02","9.01"],"status":"ready","headline":"AdaptHealth Q1 net loss $2.1M, revenue up 6.4% to $792.5M, adj. EBITDA up 18.3%","summary_kind":"llm","event_type":"earnings","confidence":"high","bullets":["Net revenue $792.5M (+6.4% YoY); net loss $2.1M vs net income $15.7M prior year.","Adjusted EBITDA $158.5M (+18.3%), margin 20.0%.","Operating cash flow $49.0M, down from $140.2M due to Change Healthcare breach; free cash flow ($38.9M).","Non-acquired revenue growth 6.2%; leverage expected below 3x in 2024.","Chairman/Interim CEO Richard Barasch stepping away; Suzanne Foster to assume leadership."],"consensus_eps_estimate":null,"consensus_eps_actual":-0.02,"consensus_revenue_estimate":null,"consensus_revenue_actual":792497000.0,"consensus_period":"2024-Q1","consensus_source":"xbrl_only","sentiment":"negative","materiality_score":0.6,"calibrated_materiality_score":0.6,"market_cap_usd":1378228528.7442086,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":228331,"accession_number":"0001104659-24-048318","cik":1725255,"company_name":"AdaptHealth Corp.","ticker":"AHCO","form_type":"8-K","filed_at":"2024-04-17T23:59:59+00:00","items":["5.02","7.01","9.01"],"status":"ready","headline":"AdaptHealth appoints Suzanne Foster CEO effective May 20; Richard Barasch to step down","summary_kind":"llm","event_type":"leadership","confidence":"high","bullets":["Suzanne Foster, former President of Beckman Coulter Life Sciences (Danaher), named CEO and board member effective May 20, 2024.","Interim CEO and Chairman Richard Barasch will cease as interim CEO on May 20, remain Chairman until June 30, then resign as director and serve as special advisor.","CEO employment agreement provides $900,000 base salary, target annual bonus of 120% of base, and inducement RSUs worth $4.9M plus $1M with multi-year vesting.","CFO Jason Clemens' employment amended to increase severance base salary payments from 12 to 18 months on qualifying termination."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.65,"calibrated_materiality_score":0.65,"market_cap_usd":1378228528.7442086,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":247054,"accession_number":"0001104659-24-030510","cik":1725255,"company_name":"AdaptHealth Corp.","ticker":"AHCO","form_type":"8-K","filed_at":"2024-03-04T23:59:59+00:00","items":["5.02","9.01"],"status":"ready","headline":"AdaptHealth extends Interim CEO Richard Barasch through April 30, 2024","summary_kind":"llm","event_type":"leadership","confidence":"high","bullets":["Interim CEO Richard Barasch will continue until April 30, 2024 (Transition Date), from prior Feb 29 end.","Monthly base salary remains $262,500; new RSU grant of $175,000 vests on Transition Date.","Third Extension RSUs fully vested as of Feb 29, 2024; no Transition Period after Interim Period ends.","Agreement amended via Fourth Extension Letter dated March 3, 2024; filed as Exhibit 10.1."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.35,"calibrated_materiality_score":0.35,"market_cap_usd":1378228528.7442086,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":247053,"accession_number":"0001628280-24-007032","cik":1725255,"company_name":"AdaptHealth Corp.","ticker":"AHCO","form_type":"8-K","filed_at":"2024-02-27T23:59:59+00:00","items":["2.02","9.01"],"status":"ready","headline":"AdaptHealth Q4/FY2023 revenue up 7.7% to $3.2B, net loss $678.9M from goodwill impairment; guides 2024","summary_kind":"llm","event_type":"earnings","confidence":"high","bullets":["FY2023 net revenue $3,200.2M (+7.7% YoY); net loss $678.9M vs $69.3M profit, driven by $830.8M pretax goodwill impairment.","Q4 net revenue $858.2M (+10%); adjusted EBITDA $204.6M (+40.2%).","FY2023 adjusted EBITDA $670.8M (+13%); free cash flow $143.2M vs ($17.6M) prior year.","Initial FY2024 guidance: net revenue $3.25-3.35B, adjusted EBITDA $650-710M, free cash flow $150-180M.","Leverage ratio improved to 3.16x from 3.69x year-end 2022."],"consensus_eps_estimate":null,"consensus_eps_actual":-5.31,"consensus_revenue_estimate":null,"consensus_revenue_actual":3200177000.0,"consensus_period":"2023-FY","consensus_source":"xbrl_only","sentiment":"neutral","materiality_score":0.75,"calibrated_materiality_score":0.75,"market_cap_usd":1378228528.7442086,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":264492,"accession_number":"0001104659-23-129725","cik":1725255,"company_name":"AdaptHealth Corp.","ticker":"AHCO","form_type":"8-K","filed_at":"2023-12-27T23:59:59+00:00","items":["5.02","9.01"],"status":"ready","headline":"AdaptHealth extends interim CEO Richard Barasch through Feb 29, 2024","summary_kind":"llm","event_type":"leadership","confidence":"high","bullets":["Richard Barasch continues as Interim CEO until Feb 29, 2024 or earlier Board determination.","Base salary remains $262,500 per month through the Transition Date.","Receives RSU grant valued at $175,000 vesting on Transition Date, effective Jan 1, 2024.","No transition period after interim period; Barasch ceases as executive officer on Transition Date."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.4,"calibrated_materiality_score":0.4,"market_cap_usd":1378228528.7442086,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":264491,"accession_number":"0001104659-23-120774","cik":1725255,"company_name":"AdaptHealth Corp.","ticker":"AHCO","form_type":"8-K","filed_at":"2023-11-22T23:59:59+00:00","items":["5.02","9.01"],"status":"ready","headline":"AdaptHealth adopts non-qualified deferred compensation plan for select executives effective Jan 2024","summary_kind":"llm","event_type":"other_material","confidence":"high","bullets":["Plan effective Jan 1, 2024; available to select management and highly compensated employees including named executive officers.","Participants may defer compensation; deferrals fully vested; Sponsor may make discretionary contributions.","Plan is unfunded, unsecured; participants are general creditors; designed to comply with Section 409A."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.3,"calibrated_materiality_score":0.3,"market_cap_usd":1378228528.7442086,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":264490,"accession_number":"0001628280-23-037167","cik":1725255,"company_name":"AdaptHealth Corp.","ticker":"AHCO","form_type":"8-K","filed_at":"2023-11-07T23:59:59+00:00","items":["2.02","9.01"],"status":"ready","headline":"AdaptHealth Q3 revenue up 6.3% to $804M; net loss $454M on $512M goodwill impairment; cuts FY EBITDA guidance","summary_kind":"llm","event_type":"earnings","confidence":"high","bullets":["Net revenue $804.0M (+6.3% YoY); net loss $454.1M vs prior year income $16.1M due to $511.9M goodwill impairment.","Adjusted EBITDA $161.2M (+0.6% YoY); YTD cash from ops $325.4M, free cash flow $76.6M.","FY23 guidance: revenue narrowed to $3.160–3.185B; EBITDA lowered to $630–650M (from $650–680M). Capex 10–12%; FCF 3–4% unchanged.","Subsequent to quarter-end, repurchased $19.4M of common stock under share repurchase authorization.","Management cites sleep product growth for record revenue; Humana contract delays weighed on EBITDA."],"consensus_eps_estimate":null,"consensus_eps_actual":-3.37,"consensus_revenue_estimate":null,"consensus_revenue_actual":2341943000.0,"consensus_period":"2023-Q3","consensus_source":"xbrl_only","sentiment":"negative","materiality_score":0.8,"calibrated_materiality_score":0.8,"market_cap_usd":1378228528.7442086,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":264489,"accession_number":"0001104659-23-113004","cik":1725255,"company_name":"AdaptHealth Corp.","ticker":"AHCO","form_type":"8-K","filed_at":"2023-10-31T23:59:59+00:00","items":["5.02","9.01"],"status":"ready","headline":"AdaptHealth extends interim CEO Richard Barasch's service through Dec 31, 2023","summary_kind":"llm","event_type":"leadership","confidence":"high","bullets":["Interim CEO Richard Barasch will serve through Dec 31, 2023 (Transition Date) or earlier Board determination.","Base salary continues at $262,500 per month through the Transition Date.","New RSU grant of $175,000 (Second Extension RSUs) to be awarded, vesting on Transition Date.","Previously granted Extension RSUs vest on Oct 31, 2023, subject to continuous employment."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.5,"calibrated_materiality_score":0.5,"market_cap_usd":1378228528.7442086,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":281724,"accession_number":"0001104659-23-102146","cik":1725255,"company_name":"AdaptHealth Corp.","ticker":"AHCO","form_type":"8-K","filed_at":"2023-09-20T23:59:59+00:00","items":["8.01"],"status":"ready","headline":"AdaptHealth and Crispin Teufel mutually terminate CEO employment agreement; interim CEO continues","summary_kind":"llm","event_type":"leadership","confidence":"high","bullets":["On September 19, 2023, AdaptHealth and Crispin Teufel mutually terminated his CEO employment agreement.","Board will resume search using an executive search firm; no successor named yet.","Chairman Richard Barasch continues as interim CEO until a permanent replacement is appointed."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.6,"calibrated_materiality_score":0.6,"market_cap_usd":1378228528.7442086,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":281723,"accession_number":"0001104659-23-096404","cik":1725255,"company_name":"AdaptHealth Corp.","ticker":"AHCO","form_type":"8-K","filed_at":"2023-08-29T23:59:59+00:00","items":["5.02","8.01","9.01"],"status":"ready","headline":"AdaptHealth extends interim CEO Barasch through Oct 31; new CEO Teufel delayed by court order","summary_kind":"llm","event_type":"litigation","confidence":"high","bullets":["Richard Barasch extends interim CEO term to Oct 31, 2023 with $262,500/month base salary and $175K RSU grant.","Court TRO bars incoming CEO Crispin Teufel from starting until Oct 15, 2023 due to Linde Group lawsuit over confidential info.","Preliminary injunction hearing scheduled for Oct 18, 2023; AdaptHealth is not a defendant in the case.","Teufel was appointed CEO effective Sept 1, 2023; start now delayed by 45 days pending court order.","Barasch's prior RSUs ($175K) vest Aug 31, 2023; new RSUs granted Sept 1 vest on Transition Date."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"negative","materiality_score":0.7,"calibrated_materiality_score":0.7,"market_cap_usd":1378228528.7442086,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":281722,"accession_number":"0001104659-23-092774","cik":1725255,"company_name":"AdaptHealth Corp.","ticker":"AHCO","form_type":"8-K","filed_at":"2023-08-17T23:59:59+00:00","items":["7.01"],"status":"ready","headline":"Linde Group sues to block AdaptHealth's new CEO Crispin Teufel from starting","summary_kind":"llm","event_type":"litigation","confidence":"high","bullets":["Linde Inc. and Lincare filed lawsuit Aug 14, 2023 in U.S. District Court for Connecticut.","Suit seeks injunction to prevent Teufel from commencing employment as AdaptHealth CEO.","Teufel appointed CEO effective Sept 1, 2023; AdaptHealth not named as defendant.","AdaptHealth contractually prohibits Teufel from using Linde confidential info; monitoring case."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"negative","materiality_score":0.65,"calibrated_materiality_score":0.65,"market_cap_usd":1378228528.7442086,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":281721,"accession_number":"0001628280-23-027927","cik":1725255,"company_name":"AdaptHealth Corp.","ticker":"AHCO","form_type":"8-K","filed_at":"2023-08-08T23:59:59+00:00","items":["2.02","9.01"],"status":"ready","headline":"AdaptHealth Q2 net revenue $793M (+9% YoY), net income flat $14M; Adj. EBITDA $171M (+14%); FY guidance narrowed","summary_kind":"llm","event_type":"earnings","confidence":"high","bullets":["Net revenue $793.3M, +9.0% YoY; non-acquired net revenue growth 8.7%.","Net income attributable $14.0M (flat YoY); Adjusted EBITDA $171.0M (+14.0%).","Year-to-date cash flow from ops $226.6M (up from $169.9M); free cash flow $54.8M (up from $15.6M).","FY2023 guidance narrowed: net revenue $3.16-3.20B (prior $3.16-3.24B); Adj. EBITDA $650-680M (prior $650-710M).","Planned CEO transition: Crispin Teufel to join as CEO in September 2023."],"consensus_eps_estimate":null,"consensus_eps_actual":0.03,"consensus_revenue_estimate":null,"consensus_revenue_actual":1537912000.0,"consensus_period":"2023-Q2","consensus_source":"xbrl_only","sentiment":"neutral","materiality_score":0.65,"calibrated_materiality_score":0.65,"market_cap_usd":1378228528.7442086,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":281720,"accession_number":"0001104659-23-084443","cik":1725255,"company_name":"AdaptHealth Corp.","ticker":"AHCO","form_type":"8-K","filed_at":"2023-07-27T23:59:59+00:00","items":["5.02","9.01"],"status":"ready","headline":"July 24, 2023: AdaptHealth enters new employment agreement with CTO Albert Prast ($450K base, 100% bonus target)","summary_kind":"llm","event_type":"leadership","confidence":"high","bullets":["Annual base salary of $450,000; target annual incentive bonus equal to 100% of base salary.","Severance: if terminated without cause or resigns for good reason, continued base salary for up to 2 years and COBRA for 9 months.","If resigns without good reason on second anniversary, unvested equity awards continue vesting through third anniversary.","Entered into restrictive covenant agreement with 18-month non-compete/non-solicit and indefinite non-disparagement.","Agreement effective July 24, 2023; replaces prior employment agreement with Aerocare Holdings from 2014."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.3,"calibrated_materiality_score":0.3,"market_cap_usd":1378228528.7442086,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":300681,"accession_number":"0001104659-23-075019","cik":1725255,"company_name":"AdaptHealth Corp.","ticker":"AHCO","form_type":"8-K","filed_at":"2023-06-27T23:59:59+00:00","items":["5.02","7.01","9.01"],"status":"ready","headline":"AdaptHealth appoints Crispin Teufel as CEO effective Sept 1, 2023; interim CEO Barasch","summary_kind":"llm","event_type":"leadership","confidence":"high","bullets":["Crispin Teufel, former CEO of Lincare Holdings, named CEO of AdaptHealth effective September 1, 2023.","Richard Barasch, Chairman, serves as interim CEO July 1–Aug 31 with $262,500/month base salary and $175k RSU.","Teufel receives $800k base salary, $450k signing bonus, and ~$5.93M in RSUs with performance-based vesting.","General Counsel Christopher Joyce resigns effective July 31, 2023."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.7,"calibrated_materiality_score":0.7,"market_cap_usd":1378228528.7442086,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":300680,"accession_number":"0001104659-23-073756","cik":1725255,"company_name":"AdaptHealth Corp.","ticker":"AHCO","form_type":"8-K","filed_at":"2023-06-22T23:59:59+00:00","items":["5.07"],"status":"ready","headline":"AdaptHealth shareholders elect directors, ratify KPMG, approve say-on-pay","summary_kind":"llm","event_type":"other","confidence":"high","bullets":["Class I directors elected: Barasch (49.2M for, 34.1M withheld) and Belinfanti (75.4M for, 7.8M withheld); broker non-votes 14.6M.","KPMG ratified as auditor: 97.3M for, 553.8K against, 13.7K abstain.","Say-on-pay approved: 82.2M for, 989.7K against, 17.2K abstain; 14.6M broker non-votes.","Quorum: 97.9M shares represented (72.93% of voting power)."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.2,"calibrated_materiality_score":0.15,"market_cap_usd":1378228528.7442086,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":300679,"accession_number":"0001628280-23-016626","cik":1725255,"company_name":"AdaptHealth Corp.","ticker":"AHCO","form_type":"8-K","filed_at":"2023-05-09T23:59:59+00:00","items":["2.02","9.01"],"status":"ready","headline":"AdaptHealth Q1 revenue +5.4% to $744.6M; adjusted EBITDA -2.7% to $134M","summary_kind":"llm","event_type":"earnings","confidence":"high","bullets":["Net revenue $744.6M, up 5.4% YoY; non-acquired growth 4.7%.","Adjusted EBITDA $134.0M, down 2.7% from $137.6M in Q1 2022.","Sleep category revenue grew 17.6% YoY; Diabetes business declined.","Net income attributable to AdaptHealth Corp. was $15.7M.","Company launched cost management program to revamp supply chain and real estate."],"consensus_eps_estimate":null,"consensus_eps_actual":-0.06,"consensus_revenue_estimate":null,"consensus_revenue_actual":744626000.0,"consensus_period":"2023-Q1","consensus_source":"xbrl_only","sentiment":"neutral","materiality_score":0.65,"calibrated_materiality_score":0.65,"market_cap_usd":1378228528.7442086,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":300678,"accession_number":"0001104659-23-057487","cik":1725255,"company_name":"AdaptHealth Corp.","ticker":"AHCO","form_type":"8-K","filed_at":"2023-05-09T23:59:59+00:00","items":["5.02","7.01","9.01"],"status":"ready","headline":"AdaptHealth CEO Stephen Griggs to step down June 30, 2023; search underway","summary_kind":"llm","event_type":"leadership","confidence":"high","bullets":["CEO Stephen Griggs resigns by mutual agreement, effective June 30, 2023.","Board initiated search for successor; Chairman Richard Barasch to serve as interim CEO if needed.","Griggs will not stand for re-election to Board at annual meeting in June 2023.","Transition agreement provides Griggs with severance benefits including vesting of equity awards.","Company affirms sound financial condition; Q1 2023 earnings reported separately."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.65,"calibrated_materiality_score":0.65,"market_cap_usd":1378228528.7442086,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":320638,"accession_number":"0001104659-23-032067","cik":1725255,"company_name":"AdaptHealth Corp.","ticker":"AHCO","form_type":"8-K","filed_at":"2023-03-14T23:59:59+00:00","items":["5.02"],"status":"ready","headline":"AdaptHealth promotes Archbold to CAO, Rietkerk to COO; Bunting transitions to advisor","summary_kind":"llm","event_type":"leadership","confidence":"high","bullets":["Christine Archbold promoted to CAO effective March 10, 2023; base salary $350k, target bonus 50% of salary.","Shaw Rietkerk promoted to COO effective March 13, 2023; target annual bonus 100% of base salary, equity target $800k/year.","Daniel Bunting transitions from COO - Field Operations to Special Advisor to CEO effective March 13, 2023.","Prior roles: Archbold SVP Corp Accounting since Oct 2022; Rietkerk COO - Centralized Operations since Feb 2021.","No arrangements/understandings with any other person; no family relationships or material interests subject to disclosure."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.5,"calibrated_materiality_score":0.5,"market_cap_usd":1378228528.7442086,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":320637,"accession_number":"0001628280-23-005273","cik":1725255,"company_name":"AdaptHealth Corp.","ticker":"AHCO","form_type":"8-K","filed_at":"2023-02-27T23:59:59+00:00","items":["2.02","9.01"],"status":"ready","headline":"AdaptHealth reports Q4 net loss, cuts 2023 guidance on cost pressures and revenue mix","summary_kind":"llm","event_type":"earnings","confidence":"high","bullets":["Full-year 2022 net revenue up 21% YoY; net income $69.3M ($0.33/diluted) vs $156.2M ($0.67) in 2021.","Q4 net loss $2.6M ($(0.02)/share) vs net income $22.9M ($0.15) in Q4 2021; adjusted EBITDA $146.0M, down 7.7% YoY.","2023 guidance cut: revenue $3.160B-$3.240B (prev $3.210B-$3.290B); adj. EBITDA $650M-$710M (prev $690M-$750M).","CEO cites larger-than-expected revenue mix and cost pressures for EBITDA miss; new cost containment programs planned.","Cash flow from operations $373.9M in 2022, up from $275.7M in 2021."],"consensus_eps_estimate":null,"consensus_eps_actual":0.33,"consensus_revenue_estimate":null,"consensus_revenue_actual":2970595000.0,"consensus_period":"2022-FY","consensus_source":"xbrl_only","sentiment":"negative","materiality_score":0.75,"calibrated_materiality_score":0.75,"market_cap_usd":1378228528.7442086,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":320636,"accession_number":"0001104659-23-002853","cik":1725255,"company_name":"AdaptHealth Corp.","ticker":"AHCO","form_type":"8-K","filed_at":"2023-01-11T23:59:59+00:00","items":["2.02","7.01","9.01"],"status":"ready","headline":"AdaptHealth guides FY2023 revenue $3.21-3.29B, adj. EBITDA $690-750M; Q4 prelim near prior ranges","summary_kind":"llm","event_type":"earnings","confidence":"medium","bullets":["FY2023 net revenue guidance $3.210B-3.290B; Adjusted EBITDA $690M-$750M; capex 9-11% of revenue.","FY2022 net revenue expected near midpoint of $2.950B-$3.010B; Adjusted EBITDA near low end of $620M-$650M.","Non-acquired net revenue growth for 2023 estimated at 8-10%, driven by stabilizing PAP device supply.","CEO cites strong demand but notes cost-of-goods inflation and labor pressures across healthcare.","Full Q4 and FY2022 results scheduled for release February 28, 2023."],"consensus_eps_estimate":null,"consensus_eps_actual":0.33,"consensus_revenue_estimate":null,"consensus_revenue_actual":2970595000.0,"consensus_period":"2022-FY","consensus_source":"xbrl_only","sentiment":"neutral","materiality_score":0.65,"calibrated_materiality_score":0.65,"market_cap_usd":1378228528.7442086,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":338770,"accession_number":"0001104659-22-129133","cik":1725255,"company_name":"AdaptHealth Corp.","ticker":"AHCO","form_type":"8-K","filed_at":"2022-12-21T23:59:59+00:00","items":["8.01"],"status":"ready","headline":"AdaptHealth extends share repurchase program through Dec 2023; $186M remaining","summary_kind":"llm","event_type":"other_material","confidence":"high","bullets":["Board extended $200M share repurchase program to Dec 31, 2023; previous expiry Dec 31, 2022.","Approximately $186M remained available as of December 15, 2022.","Repurchases may be made on open market, via Rule 10b5-1 plans, or privately.","Company intends to fund repurchases from available cash and liquidity."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.5,"calibrated_materiality_score":0.5,"market_cap_usd":1378228528.7442086,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":338769,"accession_number":"0001104659-22-115692","cik":1725255,"company_name":"AdaptHealth Corp.","ticker":"AHCO","form_type":"8-K","filed_at":"2022-11-08T23:59:59+00:00","items":["2.02","9.01"],"status":"ready","headline":"AdaptHealth Q3 revenue $756.5M (+15.8% YoY); net income drops 72% to $16.1M; FY guidance narrowed","summary_kind":"llm","event_type":"earnings","confidence":"high","bullets":["Q3 2022 net revenue $756.5M vs $653.3M in Q3 2021, +15.8%.","Net income $16.1M ($0.11 diluted EPS) vs $58.1M ($0.20) in Q3 2021.","Adjusted EBITDA $160.2M, +2.5% YoY; cash from ops $107.0M vs $27.1M.","FY2022 guidance updated: revenue $2.950B-$3.010B; adjusted EBITDA $620M-$650M.","Repurchased $10.6M of common stock during quarter under existing authorization."],"consensus_eps_estimate":null,"consensus_eps_actual":0.35,"consensus_revenue_estimate":null,"consensus_revenue_actual":2190312000.0,"consensus_period":"2022-Q3","consensus_source":"xbrl_only","sentiment":"negative","materiality_score":0.65,"calibrated_materiality_score":0.65,"market_cap_usd":1378228528.7442086,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":356125,"accession_number":"0001104659-22-087597","cik":1725255,"company_name":"AdaptHealth Corp.","ticker":"AHCO","form_type":"8-K","filed_at":"2022-08-09T23:59:59+00:00","items":["2.02","9.01"],"status":"ready","headline":"AdaptHealth Q2 net income drops to $14M; revenue up 18% on CPAP supply challenges","summary_kind":"llm","event_type":"earnings","confidence":"high","bullets":["Net revenue $727.6M, up 17.9% YoY; non-acquired revenue declined 0.3%.","Net income attributable $14.0M ($0.09 diluted EPS) vs $79.1M ($0.12) in Q2 2021.","Adjusted EBITDA $150.0M, up 1.8% YoY; margin improved 110 bps sequentially to 20.6%.","Sleep categories showed strong sequential growth as PAP machine supply improves.","FY2022 guidance maintained: revenue $2.84-3.04B, adjusted EBITDA $615-675M."],"consensus_eps_estimate":null,"consensus_eps_actual":0.24,"consensus_revenue_estimate":null,"consensus_revenue_actual":1433817000.0,"consensus_period":"2022-Q2","consensus_source":"xbrl_only","sentiment":"negative","materiality_score":0.75,"calibrated_materiality_score":0.75,"market_cap_usd":1378228528.7442086,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":374481,"accession_number":"0001104659-22-073919","cik":1725255,"company_name":"AdaptHealth Corp.","ticker":"AHCO","form_type":"8-K","filed_at":"2022-06-23T23:59:59+00:00","items":["5.07"],"status":"ready","headline":"AdaptHealth shareholders elect three Class III directors, ratify auditor, approve say-on-pay","summary_kind":"llm","event_type":"other_material","confidence":"high","bullets":["Brad Coppens, Susan Weaver, Dale Wolf elected as Class III directors; each received >82% of votes cast.","KPMG LLP ratified as independent auditor for FY2022 (95.7M for, 286.7K against, 9K abstain).","Advisory vote on executive compensation approved: 83.6M for, 1.2M against, 23.5K abstain.","Non-binding vote on frequency of say-on-pay set to one year (84.6M for one year)."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.2,"calibrated_materiality_score":0.15,"market_cap_usd":1378228528.7442086,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":374480,"accession_number":"0001104659-22-062079","cik":1725255,"company_name":"AdaptHealth Corp.","ticker":"AHCO","form_type":"8-K","filed_at":"2022-05-17T23:59:59+00:00","items":["5.02"],"status":"ready","headline":"AdaptHealth CAO Frank Mullen resigns; CFO Jason Clemens assumes principal accounting officer role","summary_kind":"llm","event_type":"leadership","confidence":"high","bullets":["Effective May 16, 2022, Frank Mullen resigned as Chief Accounting Officer for personal reasons.","CFO Jason Clemens will serve as principal accounting officer until a permanent replacement is appointed.","Jason Clemens, 44, has been CFO since August 2020; prior role was SVP and Operations CFO at MEDNAX.","Mr. Clemens' compensatory arrangements unchanged; no family or related-party transactions disclosed."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.4,"calibrated_materiality_score":0.4,"market_cap_usd":1378228528.7442086,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null}],"next_cursor":"2022-05-17T23:59:59+00:00|374480"}